Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,498 | 3 | 99.7% |
| Travel and Lodging | $24.96 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $4,402 | 2 | $0 (2022) |
| AstraZeneca UK Limited | $2,318 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,803 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,120 | 2 | AstraZeneca UK Limited ($2,318) |
| 2022 | $4,402 | 2 | Daiichi Sankyo Inc. ($4,402) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,802.50 | General |
| 10/04/2024 | AstraZeneca UK Limited | Truqap (Drug) | Consulting Fee | Cash or cash equivalent | $2,317.50 | General |
| Category: Oncology | ||||||
| 12/07/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $4,377.50 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Travel and Lodging | In-kind items and services | $24.96 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 772 | 1,155 | $296,930 | $52,920 |
| 2022 | 8 | 921 | 1,346 | $337,790 | $62,406 |
| 2021 | 8 | 848 | 1,206 | $254,895 | $56,341 |
| 2020 | 7 | 732 | 982 | $182,055 | $32,113 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2023 | 493 | 582 | $119,310 | $23,670 | 19.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 40 | 215 | $86,000 | $15,078 | 17.5% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 42 | 126 | $31,500 | $4,471 | 14.2% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2023 | 55 | 55 | $24,200 | $4,025 | 16.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 42 | 54 | $9,720 | $1,713 | 17.6% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2023 | 34 | 45 | $8,550 | $1,467 | 17.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 34 | 46 | $8,050 | $1,365 | 17.0% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2023 | 32 | 32 | $9,600 | $1,132 | 11.8% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2022 | 612 | 735 | $147,000 | $29,918 | 20.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 39 | 216 | $86,400 | $15,666 | 18.1% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2022 | 81 | 82 | $36,080 | $6,175 | 17.1% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 42 | 123 | $30,750 | $4,448 | 14.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 61 | 82 | $14,760 | $2,683 | 18.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 28 | 46 | $8,050 | $1,388 | 17.2% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2022 | 32 | 35 | $6,650 | $1,162 | 17.5% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2022 | 26 | 27 | $8,100 | $965.35 | 11.9% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2021 | 580 | 685 | $99,515 | $28,776 | 28.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2021 | 43 | 170 | $68,000 | $12,865 | 18.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2021 | 44 | 134 | $33,500 | $5,030 | 15.0% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2021 | 54 | 54 | $22,140 | $4,214 | 19.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 64 | 78 | $14,040 | $2,575 | 18.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 22 | 36 | $6,300 | $1,141 | 18.1% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2021 | 22 | 30 | $5,700 | $1,034 | 18.1% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2021 | 19 | 19 | $5,700 | $704.52 | 12.4% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2020 | 528 | 611 | $64,155 | $10,523 | 16.4% |
About Dr. Dara Ross, MD
Dr. Dara Ross, MD is a Anatomic Pathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1689831182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dara Ross, MD has received a total of $8,522 in payments from pharmaceutical and medical device companies, with $4,120 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($8,498).
As a Medicare-enrolled provider, Ross has provided services to 3,273 Medicare beneficiaries, totaling 4,689 services with total Medicare billing of $203,779. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location New York, NY
- Active Since 05/21/2008
- Last Updated 08/07/2013
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1689831182
Products in Payments
- ENHERTU (Drug) $4,402
- Truqap (Drug) $2,318
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New York
Dr. Richard Axel, M.d, M.D
Anatomic Pathology — Payments: $96,602
Dr. Jeremy Segal, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $92,539
Marc Ladanyi, Md, MD
Anatomic Pathology — Payments: $74,599
Dr. Maureen Zakowski, Md, MD
Anatomic Pathology — Payments: $45,149
Victor Reuter, Md, MD
Anatomic Pathology — Payments: $44,326
Dr. Alexandros Polydorides, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $34,029